Contract development and manufacturing organization Grand River Aseptic Manufacturing (GRAM) on Thursday announced a contract with the US Department of Health and Human Services and the US Department of Defense in bringing biopharmaceutical products to market.

Pursuant to the multi-year contract, GRAM will invest USD160m and receive USD120m from the US government to fund the expansions of its filling and finishing facilities.

In conjunction, GRAM delivers life-saving cGMP manufacturing capabilities for pharmaceutical companies and the US government through its 80,000 square-foot, large-scale filling facility and 200,000 square-foot finishing centre located in Grand Rapids.

The partnership supports the build-out of floor two in GRAM's aseptic filling facility, along with a 30,000 square-foot expansion of GRAM's finishing center, including a sterility laboratory and added warehouse space. The agreement will increase GRAM's filling capacity to a total of four isolator fill lines and further expands finishing operations with the advanced equipment and technology.

Throughout Operation Warp Speed, GRAM provided fill and finish services in the manufacturing of a COVID-19 vaccine.